Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and degeneration in multiple sclerosis.

W Brück1, C Stadelmann

  • 1Department of Neuropathology, Georg-August-Universität Göttingen, Robert-Koch-Strasse 40, D-37075, Göttingen, Germany.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|December 4, 2003
PubMed
Summary

Multiple sclerosis (MS) involves inflammation and axon damage early in the disease. Understanding these processes is key to developing therapies for progressive MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging myelin content changes: A bridge between tissue and clinics.

Revue neurologique·2026
Same author

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

Journal of neurology·2026
Same author

[COVID-19 and the central and peripheral nervous system].

Der Pathologe·2021
Same author

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient.

Multiple sclerosis and related disorders·2020
Same author

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.

Nature communications·2018
Same author

B cells in multiple sclerosis therapy-A comprehensive review.

Acta neurologica Scandinavica·2018

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system disease characterized by inflammation, demyelination, axon loss, and gliosis.
  • The relapsing-remitting phase of MS is dominated by inflammation and demyelination, while the progressive phase involves neurodegeneration and significant neuroaxonal damage.

Purpose of the Study:

  • To investigate the early occurrence and distinct phases of axon degeneration in multiple sclerosis.
  • To highlight the critical role of axon loss in persistent neurological deficits in progressive MS.
  • To underscore the need for defining mechanisms and developing axon-protective therapies.

Main Methods:

  • Review of recent studies on MS pathology.
  • Characterization of two distinct phases of axon degeneration.

Related Experiment Videos

  • Analysis of pathological hallmarks in the MS brain.

    • Main Results:

    • Axon damage is an early event in MS, occurring during lesion development.
    • Two phases of axon degeneration identified: one during active myelin breakdown, another in chronic demyelinated plaques.
    • Naked axons in chronic plaques are particularly vulnerable to further damage.

    Conclusions:

    • Axon loss is a primary driver of neurological deficits in progressive MS.
    • Understanding the mechanisms of axonal degeneration is crucial for therapeutic development.
    • There is a critical unmet need for established axon-protective therapies in MS.